Bristol-Myers Squibb's Q3 Non-GAAP Earnings Decline, Revenue Increases; 2026 Outlook Updated
Bristol-Myers Squibb (BMY) reported Q3 non-GAAP earnings Thursday of $1.35 per diluted share, down from $1.63 a year earlier. Analysts polled by FactSet expected $1.10. Revenue fo... Oops, something went wrong U.S. markets open in 1h 22m Bristol-Myers Squibb's Q3 Non-GAAP Earnings Decline, Revenue Increases; 2026 Outlook Updated Bristol-Myers…